top of page

HEK293/Human CRHR2β Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0081E

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


The CRHR2β receptor is a splice variant of the corticotropin-releasing hormone receptor 2 (CRHR2), belonging to the class B G protein-coupled receptor family. It is primarily distributed in cardiomyocytes, skeletal muscle, gastrointestinal smooth muscle, and certain brain regions (e.g., hypothalamus). Upon activation by ligands such as urocortin, it predominantly signals through the Gs protein pathway, mediating appetite suppression, delayed gastric emptying, enhanced myocardial contractility, and cardiovascular protection, playing an important role in stress responses and energy balance regulation.

 

Screeningbio’s HEK293/Human CRHR2β cell line overexpress CRHR2β and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

CRHR2

Accession Number

NM_001202475.1

Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data

HEK293/Human CRHR2β Agonist Assay. HEK293/Human CRHR2β cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/Human CRHR2β Agonist Assay. HEK293/Human CRHR2β cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


The CRHR2β receptor is a splice variant of the corticotropin-releasing hormone receptor 2 (CRHR2), belonging to the class B G protein-coupled receptor family.


It is primarily distributed in cardiomyocytes, skeletal muscle, gastrointestinal smooth muscle, and certain brain regions (e.g., hypothalamus).


Upon activation by ligands such as urocortin, it predominantly signals through the Gs protein pathway, mediating appetite suppression, delayed gastric emptying, enhanced myocardial contractility, and cardiovascular protection, playing an important role in stress responses and energy balance regulation.

Product Documentation



bottom of page